19 June 2021
Herbert Smith Freehills Advises Sponsors On Carsgen Therapeutics’ HK$3.1 Billion Hong Kong IPO
Advising firms
Deal team
17 lawyers named14 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- HKD 3.10bn (HK$3.1 billion)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- CARsgen Therapeutics Holdings Limited (Issuer)
Goldman Sachs (Underwriters)
UBS (Underwriters)